Have science, will travel

Science and medicine are truly global endeavors, and successful collaborations that transcend the borders of countries and continents ultimately benefit all of us. This is why when we learned of the Brazilian government’s Science Without Borders program, we seized on the opportunity to participate.

Science and medicine are truly global endeavors, and successful collaborations that transcend the borders of countries and continents ultimately benefit all of us. This is why when we learned of the Brazilian government’s Science Without Borders program, we seized on the opportunity to participate.

This is one of those win-win scenarios that prompts a pause of wonder that no one thought of it before now. Essentially, the program enables the consolidation and expansion of science, technology and innovation through exchange and international mobility. What’s being exchanged? Really smart Brazilian post-doctoral scientists who are coming to our sites in the United States and the United Kingdom to work on research projects, sharpen their biotechnology skills and to get a sense of industry.

In fact, we just completed the proposal selection process for up to 30 projects, for which we will recruit Brazilian post-doctoral fellows. Five candidates have already been selected, and we’re moving forward with additional recruitment to fill these other project areas.

What’s important to realize about this collaboration is that there are multiple rewards. Not only are we building goodwill among countries and between academia and industry, but there is a reciprocal sharing of knowledge and an appetite for science innovation that are recipes for good medicine in the future.

Brazilian post-doctoral scientists will work with us for two years, spanning all of our research areas that include oncology; respiratory, inflammation and autoimmune diseases; cardiovascular and metabolic diseases; infectious diseases; translational science; antibody discovery and protein engineering; and biopharmaceutical development.

Clearly, there’s a lot of opportunity for growth and expansion on both sides, and we can barely contain our anticipation as we begin this program in earnest. And, we’re not alone. There’s a lot of excitement among Brazilian post-doctoral researchers, too. In a country intent upon improving its science landscape, biologics are a hot topic, and Brazil’s science students recognize how crossing their border now opens doors for themselves and their country.

For now, this is our first Latin American academic partnership, and it’s quite significant. Our hope is that other countries will continue to recognize the value of these types of alliances, create similar programs, and that we’re able to open our doors even wider to a larger global science community.

Click here to learn more about our post-doctoral partnership with Science Without Borders.

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

MedImmune provides this link as a service to website visitors. MedImmune is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to MedImmune’s site or ‘continue’ to proceed.

You are about to access MedImmune historic archive material. Any reference in these archives to MedImmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.